Search

Search Results

• 

  Proteinuria: pathophysiology, diagnostic and therapeutic approach

  Enrico Valvo

  116-122

  30-04-2013

  2229

  PDF: 9567
• 

  The heart failure in Internal Medicine in Tuscany: the SMIT Study

  Valerio Verdiani, Grazia Panigada, Alberto Fortini, Luca Masotti, Simone Meini, Paolo Biagi, for the SMIT Study Group

  349-355

  15-12-2015

  1547

  PDF: 818

  Appendix: 992

  HTML: 748
• 

  Pregnancy and heart disease: what Internists should know

  Riccardo Gerloni, Domenico Panuccio

  288-304

  11-09-2017

  1264

  PDF: 638

  HTML: 263
• 

  Results of an observational retrospective multicenter study: “Campania INternal medicine - the Clinical INternist for heart failure”

  Fernando Gallucci, Emiliana Marrone, Roberto Nappi, Maurizio Renis, Maria Gabriella Coppola, Tiziana Ciarambino, Daniele D’Ambrosio, Ada Maffettone, Maria D’Avino, CIN CIN for HF Group Researchers

  08-05-2023

  1134

  PDF: 325

  HTML: 13
• 

  The 2023 hypertension guidelines of the European Society of Hypertension: a commentary

  Giuseppe Mancia, Guido Grassi, Enrico Agabiti-Rosei, Claudio Borghi, Maria Lorenza Muiesan, Paolo Palatini, Gianfranco Parati, Stefano Taddei, Reinhold Kreutz

  19-12-2023

  1604

  PDF: 430

  HTML: 19
• 

  Results of prospective multicenter study on heart failure on Campania Internal Medicine wards: the FASHION study

  Fernando Gallucci, Ilaria Ronga, Andrea Fontanella, Generoso Uomo, and the FASHION Study Group

  184-190

  14-06-2017

  1283

  PDF: 710

  HTML: 450
• 

  The erectile dysfunction as a cardiovascular risk factor

  Nathan Artom, Giuliano Pinna

  210-220

  04-12-2014

  1527

  PDF: 802

  HTML: 1535
• 

  Referral to sub-specialists: who have the most to gain from early specialist intervention among patients with markers of renal disease?

  Michele Meschi, Ezio Degli Esposti, Luca Degli Esposti, Francesca Spagnoli, Pasquale Gianluca Giuri, Enrico Fiaccadori, Alberto Caiazza

  161-168

  19-12-2013

  1732

  PDF: 980

  HTML: 202
• 

  Management of exacerbations of chronic obstructive pulmonary disease with a focus on comorbidities

  Jadwiga A. Wedzicha

  84-87

  24-04-2013

  947

  PDF: 495

  HTML: 322
• 

  No harm from angiotensin-converting enzyme inhibitors or angiotensin receptor inhibitors in patients with COVID-19. Results of a prospective study on a hospital-based cohort

  Gian Paolo Anzola, Clara Bartolaminelli, Gina Alessandra Gregorini, Chiara Coazzoli, Francesca Gatti, Alessandra Mora, Dimitrios Charalampakis, Andrea Palmigiano, Michele De Simone, Alice Comini, Erica Dellaglio, Salvatore Cassetti, Maurizio Chiesa, Francesca Spedini, Patrizia d'Ottavi, Maria Cristina Savio

  162-166

  18-09-2020

  733

  PDF: 411

  HTML: 12
• 

  The FADOI (Federation of Associations of Hospital Doctors on Internal Medicine) position paper on cardiovascular prevention in the higher risk complex patients

  Mauro Campanini, Giuliano Pinna, Roberto Nardi, on behalf of the FADOI Cardiovascular Prevention Position Statements Group

  387-404

  15-12-2015

  1973

  PDF: 847

  Appendix: 455

  HTML: 1459
• 

  Long-term impact of COVID-19 requiring elevated oxygen support and safety of prolonged positive pressure ventilation

  Francesca Salvotti, Riccardo Pellegrinelli, Veronica Geroldi, Francesca Leidi, Vittorio Scipione, Gigliola Flamminio, Antonella Pastori, Claudia Agabiti-Rosei, Carolina De Ciuceis, Damiano Rizzoni, Gianluca Edoardo Mario Boari

  18-10-2023

  625

  PDF: 348

  HTML: 77
• 

  The management of heart failure: a FADOI survey in the setting of Internal Medicine Units

  Fernando Gallucci

  16-02-2023

  1658

  PDF: 486

  HTML: 13
• 

  Cross sectional study on arterial hypertension in a general practice setting

  Ernesto Mola, Cristina Melgiovanni

  128-133

  23-06-2016

  1071

  PDF: 816

  HTML: 394